The global pandemic caused by the coronavirus has had far-reaching and long-lasting impacts. The disease's entire breadth has yet to be discovered. Initially, there were multiple anecdotal and published reports of eye redness and irritation in COVID-19 patients, implying that conjunctivitis is an ocular symptom of SARS-CoV-2 infection. COVID-19 has been linked to uveitic, retinovascular, and neuro-ophthalmic illness, according to new research. Based on the findings in the patients' eyes, it's been indicated that unprotected eyes can also become infected with the SAR-CoV-2 virus. The drugs used to treat COVID-19 have ocular side effects as well. Although long-term treatment of chloroquine and hydroxychloroquine can cause retinal damage, this is neither expected or seen with COVID-19.
Title : Rare and interesting case of Goldenhar’s syndrome in a 3 years old male child
Gowhar Ahmad, Florence Hospital Srinagar, India
Title : Management of common vitreoretinal lesions: An overview and update
Tim Jackson, King’s College London, United Kingdom
Title : Lumevoq gene therapy in leber hereditary optic neuropathy
Magali Taiel, GenSight Biologics, France
Title : An advanced 3D human-based in vitro model to identify disease-specific molecular markers of glaucoma neurodegeneration
Anna Maria Bassi, University of Genoa, Italy
Title : Evaluating the quality and readability of AI chatbot responses to frequently asked questions on basal cell carcinoma: Implications for patient education and digital health communication
Arrane Selvamogan, Leicestershire Partnership NHS Trust, United Kingdom
Title : Evaluating the quality and readability of AI-generated ophthalmic surgery education: A four-model comparison
Arrane Selvamogan, Leicestershire Partnership NHS Trust, United Kingdom